MERCK FAILS TO DISCLOSE MORTALITY RISK ASSOCIATED WITH VIOXX

Litigation involving drug maker Merck has revealed new information about safety concerns associated with the drug Vioxx, pulled from the market in 2004. Legal documents recently made public show the company found an increased risk in mortality rates during clinical trials to treat patients with Alzheimer’s disease but the dangers were never made clear to the public.

The JAMA REPORT

The JAMA Report is a weekly video and audio medical news service from the Journal of the American Medical Association